236 related articles for article (PubMed ID: 15471560)
1. Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers.
Takada T; Yagi Y; Maekita T; Imura M; Nakagawa S; Tsao SW; Miyamoto K; Yoshino O; Yasugi T; Taketani Y; Ushijima T
Cancer Sci; 2004 Sep; 95(9):741-4. PubMed ID: 15471560
[TBL] [Abstract][Full Text] [Related]
2. SFRP1 promoter methylation and expression in human trabecular meshwork cells.
Mao W; Rubin JS; Anoruo N; Wordinger RJ; Clark AF
Exp Eye Res; 2012 Apr; 97(1):130-6. PubMed ID: 22248913
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
[TBL] [Abstract][Full Text] [Related]
4. [Effects of 5-Aza-2-deoxycytidine on DNA methylation of anti-oncogenes in non-small cell lung cancer cells].
Fang HL; Yu ZC; Zhu HB; Jin YT
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):658-63. PubMed ID: 23159077
[TBL] [Abstract][Full Text] [Related]
5. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
[TBL] [Abstract][Full Text] [Related]
7. The Wnt antagonist sFRP1 in colorectal tumorigenesis.
Caldwell GM; Jones C; Gensberg K; Jan S; Hardy RG; Byrd P; Chughtai S; Wallis Y; Matthews GM; Morton DG
Cancer Res; 2004 Feb; 64(3):883-8. PubMed ID: 14871816
[TBL] [Abstract][Full Text] [Related]
8. Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers.
Yang ZQ; Liu G; Bollig-Fischer A; Haddad R; Tarca AL; Ethier SP
Int J Cancer; 2009 Oct; 125(7):1613-21. PubMed ID: 19569235
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of the SFRP1 gene in esophageal squamous cell carcinoma.
Meng Y; Wang QG; Wang JX; Zhu ST; Jiao Y; Li P; Zhang ST
Dig Dis Sci; 2011 Nov; 56(11):3195-203. PubMed ID: 21567192
[TBL] [Abstract][Full Text] [Related]
10. [Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer].
Dahl E; Veeck J; An H; Wiesmann F; Klopocki E; Sauter G; Kristiansen G; Hartmann A; Knüchel R
Verh Dtsch Ges Pathol; 2005; 89():169-77. PubMed ID: 18035687
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.
Kawamoto K; Hirata H; Kikuno N; Tanaka Y; Nakagawa M; Dahiya R
Int J Cancer; 2008 Aug; 123(3):535-42. PubMed ID: 18404682
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of the LDOC1 tumor suppressor gene in ovarian cancer cells.
Buchholtz ML; Brüning A; Mylonas I; Jückstock J
Arch Gynecol Obstet; 2014 Jul; 290(1):149-54. PubMed ID: 24554348
[TBL] [Abstract][Full Text] [Related]
13. Methylation-associated silencing of SFRP1 in renal cell carcinoma.
Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
Oncol Rep; 2008 Nov; 20(5):1257-63. PubMed ID: 18949430
[TBL] [Abstract][Full Text] [Related]
14. Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome.
Wang H; Fan R; Wang XQ; Wu DP; Lin GW; Xu Y; Li WY
Ann Hematol; 2013 Jan; 92(2):199-209. PubMed ID: 23093371
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis.
Veeck J; Niederacher D; An H; Klopocki E; Wiesmann F; Betz B; Galm O; Camara O; Dürst M; Kristiansen G; Huszka C; Knüchel R; Dahl E
Oncogene; 2006 Jun; 25(24):3479-88. PubMed ID: 16449975
[TBL] [Abstract][Full Text] [Related]
17. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer.
Fujikane T; Nishikawa N; Toyota M; Suzuki H; Nojima M; Maruyama R; Ashida M; Ohe-Toyota M; Kai M; Nishidate T; Sasaki Y; Ohmura T; Hirata K; Tokino T
Breast Cancer Res Treat; 2010 Aug; 122(3):699-710. PubMed ID: 19859801
[TBL] [Abstract][Full Text] [Related]
18. RUNX3 gene methylation in epithelial ovarian cancer tissues and ovarian cancer cell lines.
Zhang S; Wei L; Zhang A; Zhang L; Yu H
OMICS; 2009 Aug; 13(4):307-11. PubMed ID: 19645591
[TBL] [Abstract][Full Text] [Related]
19. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.
Kwong J; Lo KW; Chow LS; Chan FL; To KF; Huang DP
Int J Cancer; 2005 Jan; 113(3):386-92. PubMed ID: 15455391
[TBL] [Abstract][Full Text] [Related]
20. [Hypermethylation and regulation of expression of secreted frizzled-related protein genes in colorectal tumor].
Qi J; Zhu YQ; Luo J; Tao WH; Zhang JM
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):842-5. PubMed ID: 18396643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]